Fragile X Syndrome (FXS) is a genetic disorder that affects millions of people worldwide and is a leading cause of autism spectrum disorders. Researchers have identified a potential new treatment method for FXS, which involves contracting the CGG trinucleotide repeat in the FMR1 gene, thereby restoring the essential protein that is lacking in patients with FXS. The study found that the treatment resulted in improved behavior and cognitive abilities in mice models with FXS. While further trials and development are needed, this breakthrough could provide a promising new approach to treating FXS and other neurodevelopmental disorders.
Today: December 9, 2023